Onconic Therapeutics Inc. (KOSDAQ:476060)
14,730
-320 (-2.13%)
Sep 22, 2026, 3:30 PM KST
| Market Cap | 683.39B +37.0% |
| Revenue (ttm) | 82.17B +179.3% |
| Net Income | 24.25B +430.5% |
| EPS | 528.52 +375.6% |
| Shares Out | 45.41M |
| PE Ratio | 28.48 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 148,574 |
| Open | 15,070 |
| Previous Close | 15,050 |
| Day's Range | 14,660 - 15,140 |
| 52-Week Range | 8,790 - 28,900 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 6, 2026 |